Lactulose — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog	PO	0.5-1 mL/kg (or 1-5 mL per dog) for constipation; 0.5-1 mL/kg for hepatic encephalopathy	q8-12h	Duration: As needed for constipation; for hepatic encephalopathy, adjust to produce 2-3 soft stools per day Notes: Can be administered with food. For hepatic encephalopathy, titrate dose to effect.
Cat	PO	1-5 mL per cat (or 0.5-1 mL/kg) for constipation; 0.5-1 mL/kg for hepatic encephalopathy	q8-12h	Duration: As needed; for megacolon, long-term management may be required Notes: May be mixed with food. Monitor for diarrhea and adjust dose.
Horse	PO (via nasogastric tube)	0.3-0.5 mL/kg (or 150-300 mL for a 500 kg horse)	q12-24h	Duration: Until fecal output normalizes Notes: Administer via nasogastric tube. Ensure adequate hydration.
Cattle	PO	0.5-1 mL/kg	q12-24h	Duration: As needed Notes: Not commonly used; ensure adequate fluid intake.
Small Ruminants (sheep/goats)	PO	0.5-1 mL/kg	q12-24h	Duration: As needed Notes: Use with caution; monitor for bloating.
Rabbit	PO	0.5-1 mL/kg	q8-12h	Duration: As needed for GI stasis Notes: May be given with critical care diet. Ensure adequate hydration.
Birds/Poultry	PO	0.5-1 mL/kg	q12-24h	Duration: As needed Notes: Use with caution; not well-studied.
Reptiles (e.g., tortoises)	PO	0.5-1 mL/kg	q24h	Duration: As needed Notes: Ensure adequate hydration and temperature.

Clinical Indications & Species Uses

General Indications

Constipation
Fecal softening
Hepatic encephalopathy (to reduce blood ammonia)

Dog (Canine)

Constipation
Fecal impaction
Hepatic encephalopathy (adjunctive therapy)

Cat (Feline)

Constipation
Megacolon (management)
Hepatic encephalopathy (adjunctive therapy)

Horse (Equine)

Constipation
Impaction colic (as an adjunct to fluid therapy)

Cattle (Bovine)

Constipation
Rumen acidosis (not primary use)
Hepatic encephalopathy (rarely)

Small Ruminants (Sheep / Goat)

Constipation
Hepatic encephalopathy (rarely)

Rabbit & Small Mammals

Constipation
Gastrointestinal stasis (as an adjunct)

Avian & Poultry

Constipation (rarely used)

Exotic & Other Species

Constipation in reptiles (e.g., tortoises)
Hepatic encephalopathy in some exotic mammals

Pharmacology & Mechanism of Action

Drug Class: Osmotic laxative | Pharmacological Group: Synthetic disaccharide

Mechanism of Action: Lactulose is a non-absorbable synthetic disaccharide (galactose and fructose) that is not hydrolyzed by mammalian intestinal enzymes. It reaches the colon unchanged, where it is fermented by colonic bacteria (e.g., Lactobacillus, Bacteroides) into short-chain fatty acids (lactic, acetic, and formic acid). This fermentation lowers colonic pH, which promotes the retention of water and electrolytes in the intestinal lumen via osmotic effect, thereby increasing stool water content and softening feces. Additionally, the acidic environment favors the conversion of ammonia (NH3) to ammonium (NH4+), which is poorly absorbed, and it also enhances the incorporation of ammonia into bacterial proteins. This reduces plasma ammonia levels, making lactulose useful in the management of hepatic encephalopathy.

Pharmacodynamics: Lactulose produces its laxative effect by increasing intraluminal osmotic pressure, leading to water retention and stimulation of peristalsis. The onset of action for constipation is typically 24-48 hours after oral administration. For hepatic encephalopathy, the reduction in blood ammonia levels occurs over several days of therapy. The drug also alters the colonic flora, favoring saccharolytic bacteria over proteolytic bacteria, which reduces the production of ammonia and other nitrogenous compounds. The acidification of the colon also decreases the absorption of ammonia and increases its fecal excretion.

⚡ Pharmacokinetics Summary

Absorption: Lactulose is minimally absorbed from the gastrointestinal tract. Less than 3% of an orally administered dose is absorbed systemically. The absorbed fraction is excreted unchanged in the urine.

Distribution: Because of its poor absorption, lactulose is largely confined to the intestinal lumen. The small amount that is absorbed is distributed in the extracellular fluid.

Metabolism: Lactulose is not metabolized by mammalian enzymes. It is metabolized by colonic bacteria to short-chain fatty acids, carbon dioxide, and hydrogen gas.

Excretion: The majority of lactulose is excreted in the feces, either unchanged or as bacterial metabolites. The small absorbed fraction is excreted unchanged in the urine.

Half-Life: The half-life of lactulose is not well-defined due to its local action. The absorbed fraction has a half-life of approximately 1-2 hours in humans, but this is not clinically relevant.

Bioavailability: Oral bioavailability is negligible (<3%) due to lack of absorption.

Protein Binding: Not applicable; lactulose is not significantly absorbed and does not bind to plasma proteins.

Available Formulations & Strengths

Oral Solution 10 g/15 mL (667 mg/mL) (PO)

Oral Powder 10 g/packet (PO)

Oral Gel (for veterinary use) Various concentrations (PO)

Contraindications & Clinical Warnings

Contraindications:

Gastrointestinal obstruction
Intestinal perforation
Galactosemia (rare)
Hypersensitivity to lactulose or any component
Patients on a low-galactose diet (due to galactose content)

Warnings & Clinical Precautions:

Use with caution in patients with diabetes mellitus (lactulose may contain small amounts of lactose and galactose).
Use with caution in debilitated patients or those with electrolyte imbalances; monitor for dehydration and electrolyte disturbances with prolonged use.
In hepatic encephalopathy, monitor blood ammonia levels and clinical signs; adjust dose to achieve 2-3 soft stools per day.
Do not administer with other laxatives unless directed by a veterinarian.
In ruminants, use with caution as it may alter rumen flora.
For animals with megacolon, long-term management may be needed; combine with dietary changes and hydration.

Adverse Effects & Reactions

Common:

Flatulence
Abdominal cramping
Diarrhea (with high doses)
Nausea (rare)

Serious / Severe:

Electrolyte imbalance (with prolonged diarrhea)
Dehydration
Hypernatremia (in renal impairment)

Rare:

Aspiration pneumonia (if administered via nasogastric tube incorrectly)
Allergic reactions

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Antacids (e.g., magnesium/aluminum hydroxide)	May reduce the effect of lactulose by increasing colonic pH, decreasing ammonia trapping.	Moderate
Neomycin	May reduce the efficacy of lactulose by altering colonic bacteria; however, combination may be used in hepatic encephalopathy.	Moderate
Oral antibiotics (broad-spectrum)	May reduce fermentation of lactulose, decreasing its effectiveness.	Moderate
Diuretics	May increase risk of electrolyte imbalances, especially hypokalemia, when combined with lactulose-induced diarrhea.	Moderate
Corticosteroids	May increase risk of potassium loss when combined with lactulose.	Mild

Overdose & Toxicity Management

Signs of Toxicity:

Severe diarrhea
Abdominal pain
Fluid and electrolyte loss
Dehydration
Metabolic acidosis (rare)

Emergency Treatment Protocol: Discontinue lactulose. Provide supportive care including fluid and electrolyte replacement. Monitor serum electrolytes and acid-base status. In severe cases, administer anti-diarrheal agents (e.g., loperamide) only if no obstruction is present. Symptomatic treatment for abdominal cramping may be needed.

Food Animal Withdrawal Times

🥩 Meat: 0 days🥛 Milk: 0 days🥚 Eggs: 0 days

Lactulose is not systemically absorbed and is generally considered to have a zero withdrawal time in food animals. However, always follow local regulations and veterinary guidance.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature (15-30°C or 59-86°F). Avoid freezing.

Handling & Special Conditions: Keep container tightly closed. Protect from excessive heat. Do not use if solution becomes discolored or contains particulate matter.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: Not FDA-approved for veterinary use; approved for human use as a prescription or OTC laxative.

Extra-Label (Off-Label) Use: In the US, lactulose is not FDA-approved for veterinary use, but it is commonly used extra-label in animals. Extra-label use in food animals must comply with AMDUCA regulations, including a valid veterinarian-client-patient relationship and appropriate withdrawal times.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Lactulose is a safe and effective osmotic laxative used in veterinary medicine for the management of constipation and hepatic encephalopathy. It is particularly useful in cats with megacolon and dogs with chronic constipation. For hepatic encephalopathy, lactulose is often used in conjunction with dietary protein restriction and antibiotics (e.g., neomycin). The dose should be titrated to produce 2-3 soft stools per day. In food animals, lactulose is rarely used, but when used, withdrawal times are generally zero due to lack of systemic absorption. Always ensure adequate hydration during therapy. Monitor for adverse effects such as diarrhea and electrolyte imbalances, especially with prolonged use. Lactulose is contraindicated in cases of intestinal obstruction. It is generally well-tolerated, but flatulence and abdominal cramping are common initially and may subside with continued use.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)